期刊文献+

四氧嘧啶脑室内注射对小鼠学习记忆的影响 被引量:3

Effect of alloxan intraventricular injection on learning and memory abilities of mice
原文传递
导出
摘要 目的研究脑内葡萄糖代谢改变对小鼠学习记忆的影响及其在AD发病机制中的作用。方法小鼠按随机数字表法分为四氧嘧啶低剂量组(剂量1.5mg/kg)、四氧嘧啶高剂量组(剂量4mg/kg)和对照组(注射等量0.9%生理盐水),每组7只,前2组小鼠脑室内注射0位Ⅳ_乙酰葡萄糖胺(0.GIcNAc)转移酶的抑制剂四氧嘧啶,干预脑内葡萄糖代谢。Morris水迷宫实验检测小鼠学习和记忆能力,Western blotting蛋白免疫印迹和免疫组织化学染色分析小鼠脑组织细胞骨架蛋白神经丝的糖基化和磷酸化改变。结果定位航行实验:四氧嘧啶脑室内注射小鼠平均逃避潜伏期和路径长度较对照组明显增加,差异有统计学意义(P〈0.05);空间探索实验:四氧嘧啶脑室内注射小鼠穿越隐匿平台次数较对照组明显减少,初始角度(小鼠入水时游向和入水点跟平台连线的夹角)明显增加,差异均有统计学意义(P〈0.05)。与对照组比较,四氧嘧啶脑室内注射小鼠神经丝蛋白的磷酸化表达明显增加,相应分子量蛋白的糖基化表达明显减少,差异均有统计学意义(P〈0.05)。与对照脑组织比较,AD脑皮质神经丝的磷酸化表达增加而糖基化表达减少,差异有统计学意义(P〈0.05)。结论四氧嘧啶脑室内注射导致小鼠学习记忆能力的减退,其可能和脑内糖代谢改变影响细胞骨架的糖基化和磷酸化有关,并与AD脑内神经丝的糖基化和磷酸化改变相似。 Objective To investigate the effect of glucose metabolism alteration induced by alloxan intraventricular injection on learning and memory abilities of mice, and its role in the development of AD. Methods Mice were randomly divided into high-dose alloxan intraventricular injection group (n=7, 4 mg/kg) and low-dose alloxan inlraventricular injection group (n=7, 1.5 mg/kg) and control group (n=7, physiological saline); intraventricular injection of aUoxan, the O-GLcNAc traasferase inhibitor, was performed in the high-dose and low-dose alloxan intraventricular injection groups to interfere the brain glucose metabolism. Morris water maze was used to detect the learning and memory abilities of mice. Western blotting and immunohistochemistry were used to analyze the alterations of phosphorylation and O-Glycosylation of neurofilament in mice brain induced by alloxan intraventricular injection. Results In the located navigation tests, the swimming time and distance to find the platform in the mice of alloxan administration were significantly increased as compared with those in the control group (P〈 0.05); in space exploration experiments, compared with those in the control mice, the number of crossing the hidden platform was decreased and the initial angle of entry to water was increased in the mice of alloxan administration (P〈0.05). Western blotting and immunohistochemistry displayed that phosphorylation was obviously increased and the O-Glycosylation was significantly reduced in the cytoskletal neurofilament of the mice with alloxan administration ascompared with those in the control group (P〈0.05), which was similar to the alteration of neurofilament's modification in AD brain. Conclusion The inventricular injection of alloxan could impair the learning and memory of mice, which might have a relation with the dysregulation of phosphorylation and O-Glycosylation in neurofilament caused by the impaired glucose metabolism, which is similar to the alteration of phosphorylation and O-Glycosylation in neurofilament in AD brain.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第4期346-350,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30973156) 天津市科委应用基础及前沿技术研究基金(08JCYBJC27500):天津市高等学校科技发展基金(20070203) 美国NIHFIRCA国际合作项目(R03TW008123-01A1)
关键词 四氧嘧啶 阿尔茨海默病 神经丝 糖基化 磷酸化 Alloxan Alzheimer's disease Neurofilament O-Glycosylation Phosphorylation
  • 相关文献

参考文献14

  • 1Iqbal K,Alonso Adel C,El-Akkad E,et al.Alzheimer neurofibrillary degeneration:therapeutic targets and high-throughput assays[J].J Mol Neurosci,2003,20(3):425-429.
  • 2Stemberger NH,Sternberger LA,Ulrich J.Aberrant neurofilament phosphorylation in Alzheimer disease[J].Proc Natl Acad Sci USA,1985,82(12):4274-4276.
  • 3Wang J,Tung Y,Wang Y,et al.Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells[J].FEBS Lett,2001,507(1):81-87.
  • 4Liu Q,Xie F,Siedlak SL,et al.Neurofilament proteins in neurodegenerative diseases[J].Cell Mol Life Sci,2004,61 (24):3057-3075.
  • 5Gong CX,Liu F,Grundke-Iqbal I,et al.Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation[J].J Alzheimers Dis,2006,9(1):1-12.
  • 6Perrot R,Berges P,Bocquet A,et al.Review of the multiple aspects of neurofilament functions,and their possible contribution to neurodegeneration[J].Mol Neurobiol,2008,38(1):27-65.
  • 7Dong DL,Xu ZS,Hart GW,et al.Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H[J].J Biol Chem,1996,271(34):20845-20852.
  • 8Hart GW,Housley MP,Slawson C.Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins[J].Nature,2007,446(7139):1017-1022.
  • 9Deng Y,Li B,Liu F,et al.Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease[J].FASEB J,2008,22(1):138-145.
  • 10Deng Y,Li B,liu Y,et al.Dysregulation of insulin signaling,glucose transporters,O-GlcNAcylation,and phosphorylation of tau and neurofilaments in the brain:Implication for Alzheimer's disease[J].Am J Pathol,2009,175(5):2089-2098.

同被引文献41

  • 1Cork LC, Sternberger NH, Sternberger LA, et al. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's dis- ease[J]. J Neuropathol Exp Neurol,1986,45( 1 ) :56-64.
  • 2Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N- acetylglucosamine on nucleocytoplasmic proteins [ J ]. Nature, 2007,446(7139) :1017-1022.
  • 3Raina AK, Hochman A, Ickes H, et al. Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out[ J]. Prog Neuro- psychopharmacol Biol Psychiatry, 2003,27 ( 2 ) : 251-254.
  • 4Butkinaree C, Park K, Hart GW. O-linked beta-N-acetylglu- cosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress[J]. Biochim Biophys Acta,2010,1800(2) :96-106.
  • 5Deng Y, Li B, Liu F, et al. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzbeimer disease[J]. FASEB J,2008,22( 1 ) :138-145.
  • 6Deng Y, Li B, Liu Y, et al. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's dis- ease[J]. Am J Pathol,2009,175(5) :2089-2098.
  • 7Liu Q, Xie F, Siedlak SL, et al. Neurofilament proteins in neuro- degenerative diseases[ J ]. Cell Mol Life Sci, 2004,61 (24) :3057- 3075.
  • 8Jellinger KA. Cell death mechanisms in neurodegeneration [ J ]. J Cell Mol Ned, 2001,5(1) :1-17.
  • 9Yoshiura T, Hiwatashi A, Noguchi T, et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease [J]. Eur Radiol, 2009, 19(12): 2819-2825.
  • 10Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study [J]. Ann Neurol, 2005, 57(6): 789-794.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部